Suppr超能文献

胸苷酸合成酶中的D221控制构象变化,从而控制咪唑烷的打开。

D221 in thymidylate synthase controls conformation change, and thereby opening of the imidazolidine.

作者信息

Sage C R, Michelitsch M D, Stout T J, Biermann D, Nissen R, Finer-Moore J, Stroud R M

机构信息

Department of Biochemistry and Biophysics, University of California at San Francisco 94143-0448, USA.

出版信息

Biochemistry. 1998 Sep 29;37(39):13893-901. doi: 10.1021/bi9810510.

Abstract

In thymidylate synthase (TS), the invariant residue Asp-221 provides the only side chain that hydrogen bonds to the pterin ring of the cofactor, 5,10-methylene-5,6,7,8-tetrahydrofolate. All mutants of D221 except cysteine abolish activity. We have determined the crystal structures of two ternary complexes of the Escherichia coli mutant D221N. In a complex with dUMP and the antifolate 10-propargyl-5,8-dideazafolate (CB3717), dUMP is covalently bound to the active site cysteine, as usual. CB3717, which has no imidazolidine ring, is also bound in the usual productive orientation, but is less ordered than in wild-type complexes. The side chain of Asn-221 still hydrogen bonds to N3 of the quinazoline ring of CB3717, which must be in the enol form. In contrast, the structure of D221N with 5-fluoro-dUMP and 5,10-methylene-5,6,7, 8-tetrahydrofolate shows the cofactor bound in two partially occupied, nonproductive binding sites. In both binding modes, the cofactor has a closed imidazolidine ring and adopts the solution conformation of the unbound cofactor. In one of the binding sites, the pterin ring is turned around such that Asn-221 hydrogen bonds to the unprotonated N1 instead of the protonated N3 of the cofactor. This orientation blocks the conformational change required for forming covalent ternary complexes. Taken together, the two crystal structures suggest that the hydrogen bond between the side chain of Asp-221 and N3 of the cofactor is most critical during the early steps of cofactor binding, where it enforces the correct orientation of the pterin ring. Proper orientation of the cofactor appears to be a prerequisite for opening the imidazolidine ring prior to formation of the covalent steady-state intermediate in catalysis.

摘要

在胸苷酸合成酶(TS)中,不变残基天冬氨酸-221提供了唯一与辅因子5,10-亚甲基-5,6,7,8-四氢叶酸的蝶呤环形成氢键的侧链。除半胱氨酸外,D221的所有突变体均使活性丧失。我们已经确定了大肠杆菌突变体D221N的两种三元复合物的晶体结构。在与dUMP和抗叶酸剂10-炔丙基-5,8-二氮杂叶酸(CB3717)形成的复合物中,dUMP像往常一样与活性位点半胱氨酸共价结合。没有咪唑烷环的CB3717也以通常的有效方向结合,但比野生型复合物中的有序性差。天冬酰胺-221的侧链仍然与CB3717喹唑啉环的N3形成氢键,CB3717必须处于烯醇形式。相比之下,D221N与5-氟-dUMP和5,10-亚甲基-5,6,7,8-四氢叶酸的结构显示辅因子结合在两个部分占据的非有效结合位点。在两种结合模式中,辅因子都有一个封闭的咪唑烷环,并采用未结合辅因子的溶液构象。在其中一个结合位点,蝶呤环发生翻转,使得天冬酰胺-221与辅因子未质子化的N1而非质子化的N3形成氢键。这种取向阻碍了形成共价三元复合物所需的构象变化。综合起来,这两种晶体结构表明,天冬氨酸-221侧链与辅因子N3之间的氢键在辅因子结合的早期步骤中最为关键,它能确保蝶呤环的正确取向。在催化过程中形成共价稳态中间体之前,辅因子的正确取向似乎是打开咪唑烷环的先决条件。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验